Oxantel

DB13670InvestigationalSmall molecule

Oxantel is an antihelminthic indicated in the treatment of ascaris, trichocephaliasis, and oxyuriasis infections. Oxantel is an anthelmintic drug that targets parasitic acetylcholine receptors.

Chemical structure of Oxantel
Mechanism
Curator reviewed · 2 references
Formula / weight
C13H16N2O · 216.284 g/mol (avg)

Resolves to

Compound
UNII94AJJ30D9ECAS36531-26-7ChEMBLCHEMBL1240977ChEBI135610PubChem5281087
Clinical / RWD
RxNorm1871175ATCP02CC02
Structure
InChIKeyVRYKTHBAWRESFI-VOTSOKGWSA-NSMILESCN1CCCN=C1\C=C\C1=CC=CC(O)=C1
Targets
P48180acr-16

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
17Marketed productsAcross 1 country and 7 labellers
Sign in
1ATC codeIncluding every combination product, plus 9 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Oxantel, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In